Anti-N3pGlu amyloid beta antibodies and uses thereof

Methods of treating, preventing and / or retarding the progression of cognitive decline, in human subjects having a disease characterized by deposition of A[beta] in the brain including Alzheimer's disease, Down's syndrome, and cerebral amyloid angiopathy, using anti-N3pGlu A[beta] antibod...

Full description

Saved in:
Bibliographic Details
Main Authors SIMS, JOHN RANDALL, MINTUN, MARK
Format Patent
LanguageChinese
English
Published 01.01.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Methods of treating, preventing and / or retarding the progression of cognitive decline, in human subjects having a disease characterized by deposition of A[beta] in the brain including Alzheimer's disease, Down's syndrome, and cerebral amyloid angiopathy, using anti-N3pGlu A[beta] antibodies.
Bibliography:Application Number: TW202211108639